Home > News > NanoSystems And B-M Squibb Agreement For NanoCrystal Technology
September 30th, 2003
NanoSystems And B-M Squibb Agreement For NanoCrystal Technology
Abstract:
Elan Corporation announced today that its drug delivery business unit, NanoSystems, and Bristol-Myers Squibb have signed a license agreement for NanoCrystal(TM) technology. This license will provide Bristol-Myers Squibb with access to NanoCrystal technology and the right to develop and commercialize products incorporating this technology.
Source:
Businesswire
Bookmark:
| Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||